Back to the NHL Newsfeed

Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Forecast, Global Industry Analysis and Opportunity Assessment 2022-2028 | Sanofi, Mylan N.V., Teva Pharmaceutical Industries

The Gamma-aminobutyric Acid (GABA) Receptor Agonist market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Gamma-aminobutyric Acid (GABA) Receptor Agonist market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028.